Greg Johnson
InvestorFounder and Managing Director at Prolog Ventures
About
A Prolog co-founder and managing director with over 30 years in venture capital, Greg played an early-stage role in funding companies including Genelabs, Novellus, UroCor and Stereotaxis. He previously was a general partner at Gateway Associates and began his investing career in 1985 at Monsanto, where he oversaw its $80M venture portfolio. He holds a doctorate in physics from the University of Rochester and a bachelor's degree from MIT.
Invests in
Medical DevicesNew Materials
Investments
Investor
GenelabsNovellusStereotaxisUroCor
Per the firm's website.
